Skip to main content

Nonprofit · EIN 20-8735688

SOLVING KIDS CANCER INC

Tax-exempt · NEW YORK, NY 10022

Financials

$641K$1.2M2023$333K$649K2024$615K$651K2025
Revenue Expenses · by fiscal year end
Financials of SOLVING KIDS CANCER INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$615,134$651,279-$36,145$1,686,816$109,127$1,577,689
December 31, 2024990$333,401$649,223-$315,822$1,755,507$141,673$1,613,834
December 31, 2023990$641,068$1,154,712-$513,644$2,075,323$145,667$1,929,656
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$600,911
of which government grants
$105,764
Program service revenue
$0
Investment income
$39,278
Net income from fundraising events
-$25,055
Other revenue
-$25,055

Expenses

Grants and similar amounts paid
$331,876
Compensation of officers, directors and key employees
$91,000
Other salaries and wages
$72,683
Salaries, compensation and benefits (total)
$183,614
Professional fundraising fees
$43,507
Accounting fees
$27,920
Occupancy
$19,429
Travel
$3,979
Depreciation
$1,979
Program services (functional)
$453,128
Management and general (functional)
$78,041
Fundraising (functional)
$120,110

Balance sheet and other

Total assets, start of year
$1,755,507
Total assets, end of year
$1,686,816
Total liabilities, end of year
$109,127
Net assets, end of year
$1,577,689
Land, buildings and equipment
$3,959
Net assets without donor restrictions
$527,793
Net assets with donor restrictions
$1,049,896
Gross receipts
$649,414
Employees
3
Volunteers
14
Year formed
2006
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
KRISTI MCKAYEXECUTIVE DI
Officer
40$90,612$3,392
MARK SAVOYECO-CHAIR
Trustee or director, Officer
2$0$0
CHANNING STAVECO-CHAIR
Trustee or director, Officer
2$0$0
MICHELE ALEXANDERCO-SECRETARY
Trustee or director, Officer
2$0$0
CATHERINE MURCHIECO-SECRETARY
Trustee or director, Officer
2$0$0
EYAL SOFFERTREASURER
Trustee or director, Officer
2$0$0
HEARN JAY CHODIRECTOR
Trustee or director
2$0$0
LINDY GADDIRECTOR
Trustee or director
2$0$0
JOHN LONDONDIRECTOR
Trustee or director
2$0$0
MICHAEL NIEDZIELSKIDIRECTOR
Trustee or director
2$0$0
CATHERINE LONDONDIRECTOR
Trustee or director
2$0$0
DEBORAH HUGHESDIRECTOR
Trustee or director
2$0$0
CINDY CAMPBELLDIRECTOR
Trustee or director
2$0$0
JAN PLANITDIRECTOR
Trustee or director
2$0$0
990 for the year ended December 31, 2024: 12 people
NameTitleHours / weekCompensationOther / benefits
SCOTT KENNEDYFORMER EXEC
Officer
40$143,719$13,299
MARK SAVOYECO-CHAIR
Trustee or director, Officer
2$0$0
CHANNING STAVECO-CHAIR
Trustee or director, Officer
2$0$0
MICHELE ALEXANDERCO-SECRETARY
Trustee or director, Officer
2$0$0
CATHERINE MURCHIECO-SECRETARY
Trustee or director, Officer
2$0$0
EYAL SOFFERTREASURER
Trustee or director, Officer
2$0$0
KHALIL BARRAGEDIRECTOR
Trustee or director
2$0$0
HEARN JAY CHODIRECTOR
Trustee or director
2$0$0
DIALA TABETDIRECTOR
Trustee or director
2$0$0
LINDY GADDIRECTOR
Trustee or director
2$0$0
JOHN LONDONDIRECTOR
Trustee or director
2$0$0
MICHAEL NIEDZIELSKIDIRECTOR
Trustee or director
2$0$0
990 for the year ended December 31, 2023: 11 people
NameTitleHours / weekCompensationOther / benefits
SCOTT KENNEDYEXECUTIVE DI
Officer
40$142,520$14,570
KHALIL BARRAGEDIRECTOR
Trustee or director
2$0$0
HEARN JAY CHODIRECTOR
Trustee or director
2$0$0
DIALA TABETDIRECTOR
Trustee or director
2$0$0
LINDY GADDIRECTOR
Trustee or director
2$0$0
JOHN LONDONCHAIR
Trustee or director, Officer
2$0$0
MICHAEL NIEDZIELSKIDIRECTOR
Trustee or director
2$0$0
JULIA ROUXDIRECTOR
Trustee or director
2$0$0
MARK SAVOYEDIRECTOR
Trustee or director
2$0$0
EYAL SOFFERTREASURER
Trustee or director, Officer
2$0$0
CHANNING STAVESECRETARY
Trustee or director, Officer
2$0$0

Address and contacts

Address (IRS master file)
1 EAST 53RD STREET 8TH FLOOR, NEW YORK, NY 10022-4200
In care of
% SCOTT KENNEDY
Principal officer (990 for 2025)
EYAL SOFFER, 1 EAST 53RD STREET 8TH FLOOR, NEW YORK, NY 10022
Signed the 990
EYAL SOFFER, TREASURER
Phone
(212) 588-6624
Return prepared by
ALTRUIC ADVISORS CPAS

Mission

SKC IMPACTS CHILDREN THROUGH THE INITIATION OF CLINICAL RESEARCH TRIALS OF INVESTIGATIVE TREATMENT STRATEGIES. OUR VISION IS TO CONTINUE EXPANDING THE ARMAMENTARIUM OF EFFECTIVE AND LESS TOXIC TREARTMENT STRATEGIES FOR PEDIATRIC ONCOLOGISTCS TO UTILIZE, UNTIL LONG-TERM SURVIVAL IS A REALITY FORVALL CHILDREN WITH HIGH-RISK SOLID TUMORS AND BRAIN TUMORS. TO ACCOMPLISH OUR MISSION, SKC FUNDS AND ADVOCATES FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDREN WITH THE MOST FATAL PEDIATRIC CANCERS THROUGH COLLABORATIVE PARTNERSHIPS WITH THE RESEARCH COMMUNITY AND RELATED NONPROFIT STAKEHOLDERS.

990 for the year ended December 31, 2025

Program accomplishments

  • SKC LEADERSHIP AND SCIENTIFIC ADVISORS SURVEY, DISCUSS, AND PRIORITIZE THE AREAS OF GREATEST UNMET NEEDS WITHIN THE PEDIATRIC CANCER RESEARCH LANDSCAPE AND DEVELOP SPECIFIC PROGRAMS TO ADDRESS THEM. (1) SKC CONCEIVED AND ORGANIZED THE 2025 CARE FOR RARE GLOBAL STRATEGY FORUM, INVITING THE WORLD'S TOP EXPERTS IN EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR) AND ATYPICAL TERATOID RHABDOID TUMOR (ATRT), TWO RARE AND AGGRESSIVE BRAIN TUMORS THAT AFFECT VERY YOUNG CHILDREN. THE OBJECTIVES OF THE MEETING WERE TO FACILITATE THE EXCHANGE OF INFORMATION AROUND EXISTING RESEARCH PROJECTS AND BUILD COLLABORATIONS ACROSS CONTINENTS. (2) SKC ISSUED A CALL FOR PROPOSALS AS A RESULT OF THE CARE FOR RARE STRATEGY FORUM AND AWARDED 600,000 IN COLLABORATION WITH PARTNER CHARITIES TO FUND THREE PROMISING PRE-CLINICAL PROJECTS TO ADVANCE TREATMENT OPTIONS FOR ETMR AND ATRT TUMOR TYPES. (3) SKC HAS ADVISORY ROLES ON NATIONAL AND INTERNATIONAL CLINICAL TRIALS CONSORTIA, REGULATORY BODIES, MULTI STAKEHOLDER PLATFORM FOR PEDIATRIC CANCER DRUG DEVELOPMENT, PHARMACEUTICAL COMPANIES, AND BUILDS COLLABORATIONS WITH OTHER NONPROFITS TO ADVOCATE FOR AND FUND RESEARCH. SKC REVIEWS PROPOSALS FOR THE NCI FUNDED CHILDREN'S ONCOLOGY GROUP AND THE DEPARTMENT OF DEFENSE RARE CANCER RESEARCH PROGRAMMATIC PANEL. SKC WAS INVITED TO SERVE ON PANELS AND PRESENT AT SEVEN SCIENTIFIC MEETINGS IN FIVE COUNTRIES. SKC CO-AUTHORED SEVERAL PEER-REVIEWED JOURNAL ARTICLES AND PEDIATRIC ONCOLOGY TEXTBOOK CHAPTERS. THESE ROLES GIVE SKC OPPORTUNITY TO INFLUENCE RESEARCH AGENDAS AND PRIORITIES.
    Expenses $453,128 · grants $331,876

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
20-8735688
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2007
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H12)
Assets (IRS master file)
$1,686,816
Income (IRS master file)
$649,414

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$615,134$651,279$1,686,816XML
990December 2024$333,401$649,223$1,755,507XML
990December 2023$641,068$1,154,712$2,075,323XML
990December 2022$894,267$1,209,405$2,595,479IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-8735688).

Questions about SOLVING KIDS CANCER INC

What is the EIN of SOLVING KIDS CANCER INC?
The employer identification number (EIN) of SOLVING KIDS CANCER INC is 20-8735688.
Is SOLVING KIDS CANCER INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
Are donations to SOLVING KIDS CANCER INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does SOLVING KIDS CANCER INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of SOLVING KIDS CANCER INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did SOLVING KIDS CANCER INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of SOLVING KIDS CANCER INC?
The 990 for the year ended December 31, 2025 names EYAL SOFFER.
Who are the officers and directors of SOLVING KIDS CANCER INC?
The 990 for the year ended December 31, 2025 lists 14 people; 1 received compensation from the organization, the highest $90,612 (KRISTI MCKAY, EXECUTIVE DI).
How much revenue does SOLVING KIDS CANCER INC have?
On its 990 for the year ended December 31, 2025 it reported revenue of $615,134, expenses of $651,279 and total assets of $1,686,816 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York · Medical research